It has been reported that the expression of RASSF1 and FHIT is inhibited in NSCLC tumours, their downregulation interestingly also having been shown to be associated with promoter hypermethylation (Zochbauer-Muller et al, 2002). This evidence concerns the gene FHIT and non-small cell lung carcinoma.